Conformis Inc 's ROA from the second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Conformis Inc 's ROA in the second quarter of 2023?
Conformis Inc recorded a cumulative net loss of $-42 million during 12 months ending in the second quarter of 2023, resulting in a negative return on assets (ROA) of -50.36%.

However, within the Healthcare sector 687 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2023 quarter, so far to 4552, from total ROA ranking in the first quarter of 2023 at 4621.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Total Assets Change	-43.45 %	-37.01 %	-36.38 %	-34.37 %	-30.33 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-42	-44	-50	-63	-61
Return On Assets (TTM)	-50.36 %	-46.52 %	-47.65 %	-52.88 %	-45.93 %
CFMS's Total Ranking	# 4552	# 4621	# 5371	# 4882	# 4938
Total Assets (TTM) in million	64	77	89	100	112
Seq. Total Assets Change	-17.64 %	-13.21 %	-11.15 %	-10.95 %	-8.25 %
Seq. Net Income Change	-	-	-	-	-

CFMS's 5 Years Annual ROA >> Back to CFMS Management Effectiveness >> Compare CFMS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 169
Sector	# 688
Overall	# 4458

Return On Assets Statistics
High	Average	Low
11.78 %	-38.73 %	-51.42 %
(Jun 30 2021)		(Sep 30 2017)

Financial Statements
Conformis Inc 's Assets	$ 64 million	CFMS's Balance sheet
Conformis Inc 's Income	$ -13 million	Quarterly CFMS's Income Statement
CFMS's Income by Division		See CFMS's Income by Division

Annual Return On Assets	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018
Y / Y Total Assets Change	-36.38 %	108.38 %	-1.88 %	8.49 %	-32.85 %
Total Assets in million	89	140	67	68	63
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-50	-2	-24	-28	-43
Annual Return On Assets	-56.78 %	-1.73 %	-36.23 %	-41.68 %	-68.85 %

CFMS's 5 Years Annual ROA >> Back to CFMS Management Effectiveness >> Compare CFMS ROA to its Competitors

More Return On Assets Ratios
CFMS's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CFMS's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CFMS's Competitors
Subscribers only: Roa for Conformis Inc 's Suppliers
Subscribers only: Return On Assets for CFMS's Customers

You may also want to know
CFMS's Roi	CFMS's Inventory Turnover Ratio	CFMS's Growth Rates	CFMS's Dividend Comparisons
	CFMS's Profitability Ratios	CFMS's Asset Turnover Ratio	CFMS's Dividend Growth
CFMS's Roe	CFMS's Valuation Ratios	CFMS's Financial Strength Ratios	CFMS's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2023, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:10:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.